Berkeley Nutraceuticals Projects $260 Mil. In Sales In 2004
This article was originally published in The Tan Sheet
Berkeley Premium Nutraceuticals' marketing efforts will replicate the strategy of its flagship Enzyte "male enhancement" product as the firm grows its portfolio to more than 10 brands by year end, the firm says
You may also be interested in...
Lifekey Healthcare should discontinue performance and efficacy claims for its Enzyte Male Enhancement Program, due in part to insufficient clinical evidence of the product's performance and efficacy, the National Advertising Division says
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands